Baillie Gifford - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$31,839
+23.5%
231
+16.1%
0.00%
Q4 2022$25,786
+17.2%
1990.0%0.00%
Q3 2022$22,000
+46.7%
1990.0%0.00%
Q2 2022$15,000
+7.1%
199
+12.4%
0.00%
Q1 2022$14,000
-12.5%
1770.0%0.00%
Q4 2021$16,0000.0%1770.0%0.00%
Q3 2021$16,0000.0%177
-13.7%
0.00%
Q2 2021$16,000
+6.7%
2050.0%0.00%
Q1 2021$15,000
-50.0%
205
+15.2%
0.00%
Q4 2020$30,0001780.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders